Randomized trial reveals genetic mutation impacts cognitive health in individuals with CADASIL, indicating need for better management.
CADASIL - Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leuko- encephalopathy is a genetic disorder this is due to the mutation within the NOTCH3 gene.[1] NOTCH3 gene provides formation for producing the notch3 receptor proteins this is concerned within the functioning and survival of vascular smooth muscle groups. Mutation on this gene produces abnormal production of NOTCH3 receptor proteins that impairs the characteristic of the small blood vessels.[2] Clinical manifestations contain stroke, TIAs, migraine with aura, hypo densities of the white matter within the subcortical region, incidence of seizure and psychiatric disturbances and cognitive disturbances. There isn't any particular remedy for this situation it could only be treated symptomatically.[3] CADASIL is responsible for recurrent ischemic stroke during mid-adulthood and can lead to severe motor disability and cognitive decline.[4-5]
No takes yet. Share an insight, caveat, or question.
2Venkateswaramurthy Nallasamy *1Abinaya Arulappan (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: